NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
122 hedge funds and large institutions have $992M invested in NxStage Medical Inc. in 2015 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 49 increasing their positions, 38 reducing their positions, and 9 closing their positions.
359% more call options, than puts
Call options by funds: $3.98M | Put options by funds: $868K
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
29% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 38
3% more funds holding
Funds holding: 118 → 122 (+4)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
1% less capital invested
Capital invested by funds: $1B → $992M (-$8.92M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Chartwell Investment Partners
Berywn,
Pennsylvania
|
+$30.7M |
| 2 |
O
OppenheimerFunds
New York
|
+$15M |
| 3 |
Jennison Associates
New York
|
+$10.2M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.83M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$7.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$35.6M |
| 2 |
William Blair & Company
Chicago,
Illinois
|
-$19.2M |
| 3 |
Millennium Management
New York
|
-$13.3M |
| 4 |
BA
Broadview Advisors
Milwaukee,
Wisconsin
|
-$6.96M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$5.67M |
NXTM Hedge Fund Activity: Q1 2015 in Review
122 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q1 2015, worth a combined $992M — down 0.89% from $1B a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new NXTM positions and 9 closed out — a net gain of 4 holders — while 49 added to existing stakes and 38 trimmed.
The largest buyer was Chartwell Investment Partners, adding an estimated $30.7M. The largest seller was Fidelity Investments, cutting an estimated $35.6M.
- 122 institutional investors held NxStage Medical Inc. (NXTM) as of Q1 2015, up from 118 in Q4 2014.
- Funds reported $992M of NxStage Medical Inc. stock for Q1 2015, down 0.89% quarter-over-quarter.
- 13 funds opened new NxStage Medical Inc. positions in Q1 2015 and 9 closed out, a net change of +4 holders.
- The largest NxStage Medical Inc. buyer in Q1 2015 was Chartwell Investment Partners, an estimated $30.7M added.
- The largest NxStage Medical Inc. seller in Q1 2015 was Fidelity Investments, an estimated $35.6M sold.
Based on aggregated 13F filings for Q1 2015.